Table 4.
Results of multivariable regression modeling of associations with in-hospital death
VARIABLE | AOR (95% CI) | p value |
---|---|---|
Age in 10 y intervals |
1.26 (0.95-1.69) |
0.1 |
Female sex |
0.60 (0.20-1.78) |
0.4 |
PVE early recurrence |
0.88 (0.30-2.59) |
0.8 |
PVE late recurrence |
2.12 (0.80-5.58) |
0.1 |
Intravenous drug use |
0.60 (0.14-2.57) |
0.5 |
Health care associated IE |
3.35 (1.27-8.78) |
0.01 |
CoNS – associated IE |
0.50 (0.09-2.78) |
0.4 |
Staphylococcus aureus |
3.83 (0.95-15.44) |
0.058 |
Viridans group streptococci |
1.26 (0.33-4.77) |
0.7 |
Others* |
1.98 (0.58-6.80) |
0.3 |
Mitral valve involvement |
1.33 (0.53-3.30) |
0.5 |
Complications** |
5.58 (1.79-17.31) |
0.003 |
Surgery | 0.38 (0.16-0.94) | 0.04 |
CoNS, Coagulase-negative staphilococci; MSSA, Methicillin-sensitive Staphylococcus aureus; MRSA, Methicillin-resistant Staphylococcus aureus; PVE, prosthetic valve endocarditis.
*Others: Enterococcus spp, Fungi/Yeast, Gram-negative bacteria, polymicrobial.
**Complications: heart failure, renal failure, stroke, non stroke embolization, intracardiac abscess, septic shock, arrhythmias.